Dissemination of extensively drug-resistant and KPC-2 producing Klebsiella pneumoniae isolated from bloodstream infections

Journal of Infection in Developing Countries

Volumn 9, Issue 9, 2015, Pages 1016-1021

  Zhao, Feng ^a   Zhang, Jun ^a   Fu, Ying ^a   Ruan, Zhi ^a   Xie, Xinyou ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bloodstream infection; Clonal dissemination; ESBLs; Extensively drug resistant; Klebsiella pneumoniae

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; EXTENDED SPECTRUM BETA LACTAMASE; POLYMYXIN; TIGECYCLINE; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; DNA SEQUENCE; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; BACTEREMIA; CHINA; CLASSIFICATION; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MORTALITY; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY; SECRETION (PROCESS); SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84942519813     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.6679     Document Type: Article

References (16)

1. Yeh CF, Chen KF, Ye JJ, Huang CT (2014) Derivation of a clinical prediction rule for bloodstream infection mortality of patients visiting the emergency department based on predisposition, infection, response, and organ dysfunction concept. J Microbiol Immunol Infect 47: 469-477.
2. Collins VL, Marchaim D, Pogue JM, Moshos J, Bheemreddy S, Sunkara B, Shallal A, Chugh N, Eiseler S, Bhargava P, Blunden C, Lephart PR, Memon BI, Hayakawa K, AbreuLanfranco O, Chopra T, Munoz-Price LS, Carmeli Y, Kaye KS (2012) Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-betalactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 56: 2173-2177.
3. Ma X, Lu Y, Xue F (2011) Mohnarin report 2010: surveillance for resistance of bacteria causing bloodstream infection. Chinese J Nosocomiol 24: 5147-5151.
4. Ma X, Lu Y, Zheng B (2012) Ministry of Health National Antimicrobial Resistance Investigation Net annual report of 2011: bacterial distribution and resistance in bloodstream infection. Chin J Clin Pharmacol 28: 927-932.
5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, OlssonLiljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281.
6. Gouby A, Neuwirth C, Bourg G, Bouziges N, Carles-Nurit MJ, Despaux E, Ramuz M (1994) Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 32: 301-305.
7. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
8. Bouza E, Eworo A, Fernandez Cruz A, Reigadas E, Rodriguez-Creixems M, Muñoz P (2013) Catheter-related bloodstream infections caused by Gram-negative bacteria. J Hosp Infect 85: 316-320.
9. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal Mor O, Maor Y, Rahav G (2012) Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18: 54-60.
10. Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M (2013) Predictors of mortality in multidrug resistant Klebsiella pneumoniae bloodstream infections. Expert Rev Anti Infect Ther 11: 1053-1063.
11. Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, Shrestha NK, Fraser TG, van Duin D (2011) Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 69: 357-362.
12. Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, Li L (2009) Novel genetic environment of the carbapenem-hydrolyzing betalactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother 53: 4333-4338.
13. Poulou A, Voulgari E, Vrioni G, Koumaki V, Xidopoulos G, Chatzipantazi V, Markou F, Tsakris A (2013) Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J Clin Microbiol 51: 3176-3182.
14. Tawfik AF, Alswailem AM, Shibl AM, Al-Agamy MH (2011) Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Microb Drug Resist 17: 383-388.
15. Castanheira M, Farrell SE, Deshpande LM, Mendes RE, Jones RN (2013) Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother 57: 3012-3020.
16. Liu Y, Li XY, Wan LG, Jiang WY, Yang JH, Li FQ (2013) Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae isolates of sequence type 11 at a university hospital in China. Diagn Microbiol Infect Dis 76: 241-243.